Skip to main content
Screenshot of afrezza.com

Live website intelligence

afrezza.com

Take Control with Afrezza® Rapid-acting Inhaled Insulin | Afrezza

Afrezza® is the only rapid-acting inhaled insulin that delivers glucose management in moments for adults with type 1 or type 2 diabetes.

Last refresh

Updated 12d ago

Analyst read

Professional

#491.8K global rank5/100 trustHealth & WellnessStale snapshot

Detected stack

ReactWordPress

Quick read

How to read afrezza.com quickly

afrezza.com looks like health & wellness. Traffic signals point to roughly 92.6K monthly visits. Current AI trust scoring is 5/100.

What to do next

  • The stack appears to include React, WordPress.
  • Open the Traffic tab if you need audience scale and geography before outreach.
  • Open the Business tab if trust, monetization, or positioning is your first decision filter.

Provider Completeness

51/56 fields populated (91%)

11 providers

Providers with missing fields

publisher: 3/5files: 2/3radar: 2/4
View field-level status

visual: 4/4

All expected fields present

meta: 3/3

All expected fields present

seo: 5/5

All expected fields present

dns: 4/4

All expected fields present

ads: 5/5

All expected fields present

publisher: 3/5

Missing: directCount, resellerCount

files: 2/3

Missing: robotsSitemapUrls

traffic: 10/10

All expected fields present

whois: 6/6

All expected fields present

radar: 2/4

Missing: categories, sourceTimestamp

ai: 7/7

All expected fields present

Why this module matters

Business signals help answer “is this a real opportunity?”

Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.

  • Trust score and sentiment are your first risk screen.
  • Business summary and audience notes speed up qualification.
  • Ads and monetization patterns reveal how the site captures value.

Business Intelligence

Business Profile

Afrezza is a prescription pharmaceutical product - the only FDA-approved ultra rapid-acting inhaled insulin for adults with type 1 or type 2 diabetes. Manufactured by MannKind Corporation and marketed as an alternative to injectable mealtime insulin, offering blood sugar lowering effects in approximately 12 minutes through inhalation rather than injection.

Business ModelPharmaceutical/Medical Product - Prescription Drug Marketing
Target AudienceAdults (18+) with type 1 or type 2 diabetes seeking alternatives to injectable mealtime insulin; healthcare providers prescribing diabetes treatments; caregivers and family members of diabetes patients

Classification

CategoryHealth & Wellness
Sub-CategoryPharmaceuticals
diabetesinsulininhaled insulintype 1 diabetestype 2 diabetesblood sugarpharmaceuticalprescription medicationdiabetes managementmedical device

Trust & Risk

Trust Assessment

Trust Score5/100
SentimentProfessional
Spam DetectionClean

Google Ads Transparency

Is AdvertiserNot Advertising
Ad Count0
no_advertiser_idno_creative_results

Publisher Monetization

ads.txtMissing

Monetization Signals

missing_ads_txt

AI Visual Analysis

Design StyleCorporate Healthcare
VibeTrustworthy, Approachable, Lifestyle-oriented
UI Score7/100
Detected Logo Textafrezza (insulin human) Inhalation Powder

IAB Taxonomy

IAB CategoryHealth & Wellness
IAB Sub-CategoryPharmaceuticals
Confidence98%
diabetesinsulininhaled insulintype 1 diabetestype 2 diabetesblood sugarpharmaceuticalprescription medicationdiabetes managementmedical device

Business Insights

Business Model

Pharmaceutical/Medical Product - Prescription Drug Marketing model detected

Trust Level

Low trust with 5/100 score

Audience

Adults (18+) with type 1 or type 2 diabetes seeking alternatives to injectable mealtime insulin; healthcare providers prescribing diabetes treatments; caregivers and family members of diabetes patients

Keep exploring

Keep exploring from this report

Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.

Need fresh data for another site? Trigger a fresh analysis or open the directory to continue browsing.